$52M Jury Verdict Overturned In Gene Test Patent Row

Law360, New York (September 13, 2012, 5:20 PM ET) -- A Wisconsin federal judge tossed a $52 million patent infringement verdict in favor of Promega Corp., ruling Wednesday that the biotechnology company hadn't shown that the allegedly infringing Life Technologies Corp. gene testing products or their components were made in or imported to the U.S.

U.S. District Judge Barbara B. Crabb said that the particular portions of the patent statute that Promega used in its infringement theories at trial hinged on the assumption that the allegedly infringing Life Technologies genetic testing kits were either made in...
To view the full article, register now.